SCHEMBL3698748

SCHEMBL3698748

CN(Cc1cccs1)C(=O)c1cn2cc(-c3ccco3)cc(C(F)(F)F)c2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 4/20 0.40
KDM4E B2RXH2 3/20 0.40
CASP1 P29466 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PKM P14618 1/20 0.40
CASP7 P55210 1/20 0.40
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
AR P10275 1/20 0.38
RAB9A P51151 2/20 0.38
HTT P42858 1/20 0.37
TP53 P04637 2/20 0.36
ALOX15 P16050 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486958 0.82 HTT (0.47) ALDH1A1HSD17B10KDM4ECASP1MEN1
SCHEMBL3704069 0.78 ADORA2A (0.46) ALDH1A1HSD17B10KDM4ECASP1MEN1
SCHEMBL13944427 0.77 AR (0.36) ALDH1A1MEN1KMT2ASMN1; SMN2AR
SCHEMBL3698746 0.77 ALDH1A1 (0.40) ALDH1A1HSD17B10KDM4ECASP1MEN1
SCHEMBL7497818 0.74 HTT (0.37) ALDH1A1HSD17B10KDM4ECASP1MEN1
SCHEMBL7490137 0.70 HTT (0.47) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL7494559 0.69 RAB9A (0.53) ALDH1A1KDM4EMEN1KMT2APKM
SCHEMBL3694043 0.69 AR (0.36) ALDH1A1MEN1KMT2APKMSMN1; SMN2
SCHEMBL7490618 0.69 NPC1 (0.40) ALDH1A1HSD17B10KDM4EMEN1KMT2A
SCHEMBL7487823 0.69 HTT (0.44) ALDH1A1HSD17B10KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections GLAXOSMITHKLINE LLC 2012-05-17 US disclosed
EP-2187883-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2010-05-26 EP disclosed
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections GLAXOSMITHKLINE LLC 2009-07-09 US disclosed
WO-2009023179-A2 NITROGEN CONTAINING BICYCLIC CHEMICAL ENTITIES FOR TREATING VIRAL INFECTIONS GENELABS TECHNOLOGIES, INC. (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120121540-A1 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections OAT, HAVCR2, CPS1 ALDH1A1 1337/4885HSD17B10 1246/4885KDM4E 2131/4885
US-20090176778-A1 Certain nitrogen containing bicyclic chemical entities for treating viral infections OAT, HAVCR2, CPS1 ALDH1A1 1337/4885HSD17B10 1246/4885KDM4E 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.